Bayer AG reports Q3 sales of €9.7 billion and net loss of €1.0 billion
I'm PortAI, I can summarize articles.
Bayer AG reported Q3 2025 sales of €9.7 billion, a 0.9% increase year-over-year. EBITDA rose 20.8% to €1.5 billion, while core earnings per share increased 137.5% to €0.57. However, the company faced a net loss of €1.0 billion due to litigation charges. Free cash flow fell to €0.6 billion, and net financial debt decreased to €32.7 billion. The Crop Science division performed well, while Pharmaceuticals sales remained stable. Bayer confirmed its outlook and announced Dr. Judith Hartmann will join the Board of Management in 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments